Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, J. G.
Right arrow Articles by Pereira-Smith, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, J. G.
Right arrow Articles by Pereira-Smith, O. M.
[Cancer Research 66, 8356-8360, September 1, 2006]
© 2006 American Association for Cancer Research


Priority Reports

p53 Is Preferentially Recruited to the Promoters of Growth Arrest Genes p21 and GADD45 during Replicative Senescence of Normal Human Fibroblasts

James G. Jackson and Olivia M. Pereira-Smith

University of Texas Health Science Center at San Antonio, Department of Cellular and Structural Biology, Sam and Ann Barshop Institute for Longevity and Aging Studies, San Antonio, Texas

Requests for reprints: James G. Jackson, Department of Cellular and Structural Biology, Sam and Ann Barshop Institute for Longevity and Aging Studies, STCBM Building, 15355 Lambda Drive, San Antonio, TX 78245-3207. Phone: 210-562-5075; Fax: 210-562-5093; E-mail: jacksonjg{at}uthscsa.edu.

Replicative senescence is the terminal growth arrest that most normal human cells enter into after a fixed number of divisions in vitro, limiting the proliferative potential of a cell and preventing genomic instability caused by critically short telomeres. Thus, senescence presents a tumor-suppressive mechanism and a barrier to tumor formation. However, senescent cells are inherently resistant to apoptosis and, as they accumulate in aging tissues, may contribute to organ dysfunction and promote tumor progression as part of the stromal environment. Replicative life span in normal human cells can be extended by inactivation of the tumor suppressor gene p53 or its direct target, the cyclin-dependent kinase inhibitor p21, suggesting a direct role for this pathway in senescence. However, p53 recruitment to promoters of target genes during replicative senescence has not been shown in live cells. In this study, we used chromatin immunoprecipitation to determine that p53 preferentially occupied the promoters of growth arrest genes p21 and GADD45 in senescent normal human diploid fibroblasts but not the promoters of other target genes that recruited p53 following doxorubicin-induced DNA damage, such as apoptosis regulators TNFRSF10b, TNFRSF6, and PUMA. This differential recruitment of p53 in senescent versus doxorubicin-treated fibroblasts was accompanied by differences in post-translational modification of p53. These data provide mechanisms for both the growth arrest mediated by p53 and the resistant nature of senescent cells to apoptosis despite p53 activity. (Cancer Res 2006; 66(17): 8356-60)




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
L. L. Song, F. Alimirah, R. Panchanathan, H. Xin, and D. Choubey
Expression of an IFN-Inducible Cellular Senescence Gene, IFI16, Is Up-Regulated by p53
Mol. Cancer Res., November 1, 2008; 6(11): 1732 - 1741.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. Mudhasani, Z. Zhu, G. Hutvagner, C. M. Eischen, S. Lyle, L. L. Hall, J. B. Lawrence, A. N. Imbalzano, and S. N. Jones
Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells
J. Cell Biol., October 22, 2008; 181(7): 1055 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. S. M. Shih, S. H. K. Wong, N. W. Schoene, and K. Y. Lei
Suppression of Gadd45 Alleviates the G2/M Blockage and the Enhanced Phosphorylation of p53 and p38 in Zinc Supplemented Normal Human Bronchial Epithelial Cells
Experimental Biology and Medicine, March 1, 2008; 233(3): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Marusyk, L. J. Wheeler, C. K. Mathews, and J. DeGregori
p53 Mediates Senescence-Like Arrest Induced by Chronic Replicational Stress
Mol. Cell. Biol., August 1, 2007; 27(15): 5336 - 5351.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. S. A. Coates, B. E. Lehnert, S. Sharma, S. M. Kindell, and R. K. Gary
Beryllium Induces Premature Senescence in Human Fibroblasts
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 70 - 79.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.